International Journal of Clinical Medicine
Vol.3 No.4(2012), Paper ID 20886, 7
pages
DOI:10.4236/ijcm.2012.34052
Survival Outcome in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Followed by Cetuximab
Kozo Kataoka, Akiyoshi Kanazawa, Akio Nakajima, Hisahiro Hosogi, Seiichiiro Kanaya, Takeshi Nagasaka, Yukihiro Kono
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Gastroenterological Surgery and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Copyright © 2012 Kozo Kataoka, Akiyoshi Kanazawa, Akio Nakajima, Hisahiro Hosogi, Seiichiiro Kanaya, Takeshi Nagasaka, Yukihiro Kono et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
K. Kataoka, A. Kanazawa, A. Nakajima, H. Hosogi, S. Kanaya, T. Nagasaka and Y. Kono, "Survival Outcome in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Followed by Cetuximab,"
International Journal of Clinical Medicine, Vol. 3 No. 4, 2012, pp. 263-269. doi:
10.4236/ijcm.2012.34052.